Research Results from European Medicines Agency Update Understanding of Vaccines

2011 AUG 31 -- Investigators publish new data in the report "Safety monitoring of Influenza A/H1N1 pandemic vaccines in EudraVigilance." According to the authors of recent research published in the journal Vaccine, "The 14,543 spontaneous reports of suspected adverse reactions received in EudraVigilance from 1 November 2009 to 30 April 2010 for three centrally authorized Influenza A/H1N1 vaccines marketed in the European Economic Area (Celvapan, Focetria and Pandemrix) were extracted to evaluate the effectiveness of recommendations to strengthen pharmacovigilance systems during the pandemic and illustrate methods of signal detection used by the European Medicines Agency...

Want to see the full article?

• Purchase this article for only $3.00